Cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) versus gemcitabine, cisplatin and methyl prednisolone (GEMP) in the first line treatment Of T-cell Lymphoma, a multicentre randomised phase II study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Cyclophosphamide; Doxorubicin; Gemcitabine; Methylprednisolone; Prednisolone; Vincristine
- Indications Anaplastic large cell lymphoma; Peripheral T-cell lymphoma; T-cell lymphoma
- Focus Therapeutic Use
- Acronyms CHEMO-T
- 15 Mar 2018 Biomarkers information updated
- 11 Dec 2013 Accrual to date is 8% according to United Kingdom Clinical Research Network record.
- 03 Nov 2013 Accrual to date is 7% according to United Kingdom Clinical Research Network record.